Daniel Miles, MD
Orthopaedic Trauma · New Orleans, LANPI 1124525258
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (32.1%), education and grants — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Smith+Nephew at 48.7% of the total.
Across 106 payments — averaging $250.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$13K
- Stryker$5K
- Polynovo North America LLC$4K
- Globus Medical$2K
- Arthrex$766
- ALON Medical Technology$656
- plus $2K from 11 others
What the payments were for
- Consulting fees$3,00011%
- Grants$5,00019%
- Travel & lodging$8,54232%
- Food & beverage$4,91218%
- Education$5,13019%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 20 | $12,948 |
| Stryker | 22 | $4,537 |
| Polynovo North America LLC | 3 | $3,969 |
| Globus Medical | 16 | $2,064 |
| Arthrex | 15 | $766 |
| ALON Medical Technology | 4 | $656 |
| Johnson & Johnson(2 entities) | 9 | $652 |
| Biocomposites Inc | 1 | $150 |
| Seapearl East, Inc | 1 | $147 |
| Bioventus LLC | 3 | $147 |
| Curvafix, Inc. | 1 | $140 |
| Medical Device Business Services, Inc. | 1 | $130 |
| Bone Support Inc. | 1 | $126 |
| Merck | 5 | $92 |
| Genentech USA, Inc. | 2 | $30 |
| Heron Therapeutics, Inc. | 1 | $16 |
| Agios Pharmaceuticals, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Novosorb BTM$3,969
- EVOS$2,173
- MAKO$2,129
- TRIGEN InterTAN$1,805
- PRO$1,772
- PRECICE Intramedullary Limb Lengthening System$1,079
- A/R Femoral Nail$406
- VA-LCP$268
- NA$268
- Journey II$260
- Actishield$153
- Stimulan$150
- Actify$142
- CurvaFix IM Implant$140
- Ankle Fracture System$137
- REAL INTELLIGENCE$130
- Anthem$129
- CERAMENTBONE VOID FILLER$126
- CERAMENT G$126
- TRIATHLON$111
How this compares
Too few orthopaedic trauma providers in Louisianato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Naproxen | 20 | $149 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic trauma in New Orleans
- Paul GladdenNew Orleans$314K
- Krishna VemulapalliNew Orleans$170K
- Murphy MartinNew Orleans$85K
- Avrey NovakNew Orleans$21K
- Olivia LeeNew Orleans$4K
- James MautnerNew Orleans$3K
- Vince LandsHammond$30K
- James HlavacekLafayette$14K
- Elliott NipperMonroe$10K
- Peter KrauseKenner$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.